Engineering T Cell Recognition: From Antigen Discovery to Programmable Immunotherapy
Places are limited, and registration is required. Please register in advance.
Effective cancer immunotherapy requires identifying tumor-associated antigens and engineering T cells to recognize them precisely. I will discuss our recent development of complementary technologies: HLA-Shuttle, which reveals hidden antigens in immune-cold tumors; HLA3DB, a database of peptide conformational features; and TRACeR-I, a protein engineering platform for developing antigen-specific binding modules with programmable HLA restriction. Together, these tools address key bottlenecks in the antigen discovery-to-therapy pipeline
Date: 2 March 2026, 13:00
Venue: Zoom, registration is required
Speaker: Nikolaos Sqourakis (University of Pennsylvania)
Organising department: MRC Weatherall Institute of Molecular Medicine
Organisers: Hashem Koohy (University of Oxford), WIMM Academics
Organiser contact email address: hashem.koohy@rdm.ox.ac.uk
Part of: Unravelling T Cell Recognition: Insights from immunology and AI
Booking required?: Required
Booking url: https://bit.ly/3O7u9PG
Cost: 0
Audience: Public
Editor: Hashem Koohy